Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide +/- Rituximab in Relapsed/Refractory CLL
NCT00096044Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Mar 2004
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), sponsored by Roswell Park Comprehensive Cancer Center. Started Mar 2004; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00096044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096044.